{"id":"NCT00307437","sponsor":"Centocor Research & Development, Inc.","briefTitle":"A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Psoriasis","officialTitle":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial Evaluating the Efficacy and Safety of CNTO 1275 in the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-05","primaryCompletion":"2006-12","completion":"2011-10","firstPosted":"2006-03-28","resultsPosted":"2012-11-02","lastUpdate":"2013-01-24"},"enrollment":1230,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Psoriasis"],"interventions":[{"type":"DRUG","name":"Placebo; Ustekinumab (CNTO 1275) 45 or 90 mg","otherNames":[]},{"type":"DRUG","name":"Ustekinumab (CNTO 1275) 45 mg","otherNames":[]},{"type":"DRUG","name":"Ustekinumab (CNTO 1275) 90 mg","otherNames":[]}],"arms":[{"label":"Group I: Placebo","type":"PLACEBO_COMPARATOR"},{"label":"Group II: Ustekinumab 45 mg","type":"EXPERIMENTAL"},{"label":"Group III: Ustekinumab 90 mg","type":"EXPERIMENTAL"}],"summary":"The primary objective of this study is to evaluate the efficacy and safety of ustekinumab (CNTO 1275) in the treatment of patients with moderate to severe plaque psoriasis.","primaryOutcome":{"measure":"Number of Participants With Psoriasis Area and Severity Index (PASI) Score of 75 Percent or Above at Week 12","timeFrame":"Week 0 to Week 12","effectByArm":[{"arm":"Group I: Placebo","deltaMin":15,"sd":null},{"arm":"Group II: Ustekinumab 45 mg","deltaMin":273,"sd":null},{"arm":"Group III: Ustekinumab 90 mg","deltaMin":311,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":11},"locations":{"siteCount":62,"countries":["United States","Austria","Canada","France","Germany","Switzerland","United Kingdom"]},"refs":{"pmids":["30739254","18486740"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":410},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Headache","Arthralgia","Hypertension"]}}